Changeflow GovPing Trade & Sanctions Harmonizing NIH Intervention Definition with Co...
Routine Notice Amended Final

Harmonizing NIH Intervention Definition with Common Rule

Favicon for grants.nih.gov NIH Guide Weekly Index
Published March 27th, 2026
Detected March 27th, 2026
Email

Summary

The National Institutes of Health (NIH) has updated its definition of 'intervention' to align with the 2018 Common Rule (45 CFR 46, Subpart A). This change aims to harmonize implementation across federal agencies and will be reflected in NIH websites and forms. The notice was released on March 27, 2026.

What changed

The NIH has officially adopted the definition of 'intervention' as provided in the 2018 Common Rule (45 CFR 46, Subpart A), replacing its previous 2014 definition. This harmonization aims to ensure consistency in how research involving human subjects is classified and regulated across federal agencies. The NIH will update its relevant websites and forms to reflect this change.

Compliance officers and researchers should review the updated definition to ensure accurate classification of studies. While this is a harmonization of definitions and not a new compliance deadline, it is crucial to understand how this change might affect the categorization of research projects, particularly those involving physical procedures or manipulations for research purposes. The NIH has provided guidance on distinguishing clinical trials, basic experimental studies involving humans (BESH), and observational studies.

What to do next

  1. Review the updated NIH definition of 'intervention' to ensure accurate study classification.
  2. Update internal documentation and processes as needed to reflect the harmonized definition.

Source document (simplified)

Harmonizing the NIH Definition of “Intervention” with the Common Rule Notice Number: NOT-OD-26-063

Key Dates

Release Date: March 27, 2026

Related Announcements

None

Issued by

NATIONAL INSTITUTES OF HEALTH (NIH)

Purpose

In 2014, the NIH revised its definition of a clinical trial (NOT-OD-15-015) to increase transparency and accountability and enhance the precision of the information NIH collects, tracks, and reports on clinical trials. In the context of the NIH clinical trial definition, the NIH also defined an intervention as:

A manipulation of the subject or subject’s environment for the purpose of modifying one or more health-related biomedical or behavioral processes and/or endpoints.

These efforts preceded the 2018 Common Rule (45 CFR 46, Subpart A [Protection of Human Subjects]), which defined an intervention as:

Both physical procedures by which information or biospecimens are gathered (e.g., venipuncture) and manipulations of the subject or the subject's environment that are performed for research purposes.

NIH adopted an implementation approach that operationalized these definitions in a similar manner. However, to ensure consistency and harmonize implementation of the Common Rule across federal agencies, effective with the publication of this Notice, NIH is adopting the definition of an intervention as defined in 45 CFR 46, Subpart A, above. The NIH will make revisions to its websites and forms, as needed, to reflect this change.

Guidance on determining whether a research study with human subjects is considered by the NIH to be a clinical trial, a basic experimental study involving humans (BESH), or an observational study can be found on the Is My Project a Clinical Trial, Basic Experimental Study Involving Humans (BESH), or an Observational Study Involving humans webpage.

Inquiries

Please direct all inquiries to:

The Office of Policy for Extramural Research Administration, OER
Division of Grants Policy
Email: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices Department of Health
and Human Services (HHS) NIH... Turning Discovery Into Health ®

CFR references

45 CFR 46

Named provisions

Intervention Definition

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
NIH
Published
March 27th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive
Document ID
NOT-OD-26-063
Supersedes
NOT-OD-15-015

Who this affects

Applies to
Healthcare providers Researchers
Industry sector
6211 Healthcare Providers 3254 Pharmaceutical Manufacturing
Activity scope
Human Subjects Research Clinical Trial Definition
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Research Oversight Human Subjects Protection

Get Trade & Sanctions alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when NIH Guide Weekly Index publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.